Methylbutyltryptamine

MBT, or N-methyl-N-butyltryptamine, is a lesser-known psychedelic drug. MBT was first synthesized by Alexander Shulgin. In his book TiHKAL (Tryptamines I Have Known and Loved), the minimum dosage is listed as 250-400 mg, and the duration listed as 4–6 hours. MBT produces a heavy body load with dehydration, and causes visuals similar to those of DMT. Very little data exists about the pharmacological properties, metabolism, and toxicity of MBT.

Methylbutyltryptamine
Names
Preferred IUPAC name
N-[2-(1H-Indol-3-yl)ethyl]-N-methylpropan-1-amine
Other names
N-methyl-N-butyltryptamine
Identifiers
3D model (JSmol)
ChemSpider
  • InChI=1S/C15H22N2/c1-3-4-10-17(2)11-9-13-12-16-15-8-6-5-7-14(13)15/h5-8,12,16H,3-4,9-11H2,1-2H3 Y
    Key: PUEYINPKMCBJCA-UHFFFAOYSA-N Y
  • InChI=1/C15H22N2/c1-3-4-10-17(2)11-9-13-12-16-15-8-6-5-7-14(13)15/h5-8,12,16H,3-4,9-11H2,1-2H3
    Key: PUEYINPKMCBJCA-UHFFFAOYAE
  • CCCCN(C)CCc2c[nH]c1ccccc12
Properties
C15H22N2
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Y verify (what is YN ?)
Infobox references

MSBT

TiHKAL mentions that a structural isomer of MBT exists, with the butyl group attached at the nitrogen atom. It is known as N-s-butyl-N-methyltryptamine, or MSBT. However, little is known about its psychoactivity.

See also


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.